Digital Twins for Personalized Healthcare: Application to Radiopharmaceutical Therapies



There is significant interest and value in utilizing digital twins (DTs) to extend healthcare from ‘one-size-fits-all’ to personalized therapies. Radiopharmaceutical therapies (RPTs), which represent very powerful developments in the battle against cancer, are no exceptions to this. In fact, theranostic digital twins (TDTs), which we elaborate in this work, present viable and feasible approaches to personalize RPTs. TDTs are computational representations of the human body that, unlike images, are operable; i.e. virtual trials can be conducted on them to propose optimal therapies for individual patients. TDTs can be built using physiologically based pharmacokinetic (PBPK) models. This work elaborates that TDTs can be developed in static, dynamic and interactive modes towards routine use in future clinical settings. TDTs will open a new area of theranostics research and development in terms of new radiopharmaceutical designs, synthesis and enabling of more optimal therapies.

IssueVol 10 No 1 (2023) QRcode
DOI https://doi.org/10.18502/fbt.v10i1.11505
Digital Twins Radiopharmaceutical Therapies Theranostics Personalized therapy PBPK models

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Abdollahi H, Rahmim A. Digital Twins for Personalized Healthcare: Application to Radiopharmaceutical Therapies. Frontiers Biomed Technol. 2022;10(1):1-5.